NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for pr...

Full description

Saved in:
Bibliographic Details
Main Authors KIM, HEE-DOO, RYU, CHONG HYON, PARK, SEOL RIN, KIM, SUNG-IL, LEE, KI-WHA, MOH, JOO HYUN, LIM, KYUNG MIN, LEE, YONG-SIL, CHOI, JIN KYU, SUH, YOUNG-GER, JEONG, YEON SU, KIM, JIN KWAN, KOH, HYUN JU, BAE, JOON HO, KIM, SUN-YOUNG, PARK, HYEUNG-GEUN, OH, UH TAEK, SHIN, SONG SEOK, PARK, YOUNG-HO
Format Patent
LanguageEnglish
French
German
Published 31.08.2011
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, and heart disease.
Bibliography:Application Number: EP20060716438